ArticleCancer immunology, immunotherapy : CII2026
Timing of immune checkpoint inhibitors infusion and prognosis in recurrent/metastatic nasopharyngeal carcinoma: a single-center, retrospective study.
Lin Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.